Evidence map›Paper›PMID 38773368›Full record

ArticleGenetics, selection, evolution : GSE2024

A recurrent de novo missense mutation in COL1A1 causes osteogenesis imperfecta type II and preterm delivery in Normande cattle.

Julien Corbeau, Cécile Grohs, Jeanlin Jourdain, Mekki Boussaha, Florian Besnard, Anne Barbat, Vincent Plassard, Julie Rivière, Christophe Hamelin, Jeremy Mortier and 3 more

Abstract read
In one paragraph

Article in Genetics, selection, evolution : GSE, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Effect of methylation on genome mutability in cattle.Genetics, selection, evolution : GSE · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Julien CorbeauBioEpAR, INRAE, Oniris, CS, 40706, Nantes, France. juliencorbeau5@gmail.com.
Cécile GrohsINRAE, AgroParisTech, GABI, Université Paris Saclay, 78350, Jouy-en-Josas, France. cecile.grohs@inrae.fr.ORCID http://orcid.org/0000-0002-3563-8966
Jeanlin JourdainELIANCE, 75012, Paris, France.
Mekki BoussahaINRAE, AgroParisTech, GABI, Université Paris Saclay, 78350, Jouy-en-Josas, France.
Florian BesnardIDELE, 75012, Paris, France.
Anne BarbatINRAE, AgroParisTech, GABI, Université Paris Saclay, 78350, Jouy-en-Josas, France.
Vincent PlassardEcole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
Julie RivièreINRAE, AgroParisTech, GABI, Université Paris Saclay, 78350, Jouy-en-Josas, France.
Christophe HamelinINNOVAL, 35538, Noyal Sur Vilaine, France.
Jeremy MortierEcole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
Didier BoichardINRAE, AgroParisTech, GABI, Université Paris Saclay, 78350, Jouy-en-Josas, France.
Raphaël GuatteoBioEpAR, INRAE, Oniris, CS, 40706, Nantes, France.
Aurélien CapitanINRAE, AgroParisTech, GABI, Université Paris Saclay, 78350, Jouy-en-Josas, France. aurelien.capitan@inrae.fr.

Funding

Agence Nationale de la Recherche ANR-14_CE 19-0011APIS-GENE BOVANOAPIS-GENE Effitness
6 · The paper itself

Abstract

backgroundNine male and eight female calves born to a Normande artificial insemination bull named "Ly" were referred to the French National Observatory of Bovine Abnormalities for multiple fractures, shortened gestation, and stillbirth or perinatal mortality.

resultsUsing Illumina BovineSNP50 array genotypes from affected calves and 84 half-sib controls, the associated locus was mapped to a 6.5-Mb interval on chromosome 19, assuming autosomal inheritance with germline mosaicism. Subsequent comparison of the whole-genome sequences of one case and 5116 control genomes, followed by genotyping in the affected pedigree, identified a de novo missense substitution within the NC1 domain of the COL1A1 gene (Chr19 g.36,473,965G > A; p.D1412N) as unique candidate variant. Interestingly, the affected residue was completely conserved among 243 vertebrate orthologs, and the same substitution in humans has been reported to cause type II osteogenesis imperfecta (OI), a connective tissue disorder that is characterized primarily by bone deformity and fragility. Moreover, three COL1A1 mutations have been described to cause the same syndrome in cattle. Necropsy, computed tomography, radiology, and histology confirmed the diagnosis of type II OI, further supporting the causality of this variant. In addition, a detailed analysis of gestation length and perinatal mortality in 1387 offspring of Ly and more than 160,000 progeny of 63 control bulls allowed us to statistically confirm in a large pedigree the association between type II OI and preterm delivery, which is probably due to premature rupture of fetal membranes and has been reported in several isolated cases of type II OI in humans and cattle. Finally, analysis of perinatal mortality rates and segregation distortion supported a low level of germ cell mosaicism in Ly, with an estimate of 4.5% to 7.7% of mutant sperm and thus 63 to 107 affected calves born. These numbers contrast with the 17 cases reported and raise concerns about the underreporting of congenital defects to heredo-surveillance platforms, even for textbook genetic syndromes.

conclusionsIn conclusion, we describe a large animal model for a recurrent substitution in COL1A1 that is responsible for type II OI in humans. More generally, this study highlights the utility of such datasets and large half-sib families available in livestock species to characterize sporadic genetic defects.

Indexed as

Collagen Type ICollagen Type I, alpha 1 ChainMutation, MissenseOsteogenesis ImperfectaAnimalsCattleCattle DiseasesFemaleMalePedigreePregnancyPremature BirthCollagen Type ICollagen Type I, alpha 1 Chain

Identifiers

PMID38773368
PMCPMC11107018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.